Increased Duodenal Iron Absorption through Upregulation of Ferroportin 1 due to the Decrement in Serum Hepcidin in Patients with Chronic Hepatitis C

Figure 1

Serial changes in sFe (a) and Tf sat (b) after administration of sodium ferrous citrate. Closed circles indicate patients with CHC; open circles indicate controls. Compared to the control group, sFe and Tf sat were significantly increased in the patients with CHC (repeated-measures ANOVA. <0.001). These data show that iron absorption from the GI tract was significantly increased in the CHC patients.

(a)

(b)